Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Irene Caruso MD

Irene Caruso MD

Research Fellow in Endocrinology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy

Irene Caruso is a Research Fellow in the Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases at the University of Bari Aldo Moro, Bari, Italy.

She is a member of the Educational Board of the Italian Diabetes Society (SID) and the Editorial Board for Journal of Endocrinological Investigation.

Her research interests are innovative treatment options for type 2 diabetes and their cardiovascular and renal benefits. Her scientific production mostly concerned the interpretation of the cardiovascular and renal benefits of GLP-1 receptor agonists and SGLT-2 inhibitors in cardiovascular outcome trials (CVOT) and real-world studies, by means of statistical methods such as meta-analysis and propensity score matching. She is currently exploring the role of tirzepatide in the management of type 2 diabetes undertaking both clinical and basic research projects.


Dr. Caruso reports the following:
  • Lectures, presentations, or educational events: Eli Lilly, NovoNordisk